ProPhase Labs, Inc. (PRPH) — Analyst outlook / Analyst consensus target is. Based on 2 analyst ratings, the consensus is bullish — 1 Buy, 1 Hold.
The consensus price target is $14.00, representing an upside of 9214.7% from the current price $0.15.
Analysts estimate Earnings Per Share (EPS) of $-12.70 and revenue of $0.01B for the next fiscal year.
Earnings Per Share (EPS) track record: 2024: actual $-2.43 vs est $-12.70 (beat +80.9%). Analyst accuracy: 0%.
PRPH Stock — 12-Month Price Forecast
$14.00
▲ +9,214.70% Upside
Average Price Target
Based on 2 Wall Street analysts offering 12-month price targets for ProPhase Labs, Inc., the price target is $14.00.
The average price target represents a +9,214.70% change from the last price of $0.15.
PRPH Analyst Ratings
Buy
Based on 2 analysts giving stock ratings to ProPhase Labs, Inc. in the past 3 months
EPS Estimates — PRPH
0%
Analyst Accuracy
Inaccurate
1 year compared
Actual vs Estimate
2024
Actual –$2.43
vs Est –$12.70
▲ 422.6% off
Profitability Outlook
Company has been making losses in all recent fiscal years. Analysts expect losses to continue near-term.
Revenue Estimates — PRPH
8%
Analyst Accuracy
Inaccurate
1 year compared
Actual vs Estimate
2024
Actual $0.007B
vs Est $0.013B
▼ 92.3% off
Revenue Trend
Analysts forecast significant revenue growth ahead.
